New drug combo tested to delay prostate cancer progression
Disease control
Completed
This study tested whether adding two drugs, abiraterone acetate and prednisone, to standard hormone therapy could better control advanced prostate cancer that had not yet spread to other body parts. It involved 131 men whose cancer was resistant to standard hormone treatment but …
Phase: PHASE2 • Sponsor: Janssen Biotech, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC